These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27932156)

  • 1. Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report.
    Smith B; Kumar V; Mompoint-Williams D; Reed RD; MacLennan PA; Stegner K; Locke JE
    Transplant Proc; 2016 Nov; 48(9):3099-3105. PubMed ID: 27932156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: Eculizumab rescue of severe accelerated antibody-mediated rejection after ABO-incompatible kidney transplant.
    Stewart ZA; Collins TE; Schlueter AJ; Raife TI; Holanda DG; Nair R; Reed AI; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3033-6. PubMed ID: 23195021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eculizumab for Prevention of Antibody-Mediated Rejection in Blood Group-Incompatible Renal Transplantation.
    West-Thielke P; Progar K; Campara M; Jasiak N; Gallon L; Tang I; Spaggiari M; Tzvetanov I; Benedetti E
    Transplant Proc; 2018; 50(1):66-69. PubMed ID: 29407333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation.
    Orandi BJ; Zachary AA; Dagher NN; Bagnasco SM; Garonzik-Wang JM; Van Arendonk KJ; Gupta N; Lonze BE; Alachkar N; Kraus ES; Desai NM; Locke JE; Racusen LC; Segev DL; Montgomery RA
    Transplantation; 2014 Oct; 98(8):857-63. PubMed ID: 25121475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Term Outcomes of ABO-Incompatible Living Donor Kidney Transplantation With Uniform Protocol: Significance of Baseline Anti-ABO Titer.
    Lee KW; Park JB; Oh DK; Na BG; Choi JY; Cho WT; Lee SH; Park HJ; Cho D; Huh WS; Kim SJ
    Transplant Proc; 2016 Apr; 48(3):820-6. PubMed ID: 27234744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of the inefficacy of eculizumab in two cases of severe antibody-mediated rejection of renal grafts.
    Burbach M; Suberbielle C; Brochériou I; Ridel C; Mesnard L; Dahan K; Rondeau E; Hertig A
    Transplantation; 2014 Nov; 98(10):1056-9. PubMed ID: 24839895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Prolonged Treatment With Intravenous Immunoglobulin Infusions for Acute Antibody-mediated Rejection in Kidney Transplant Recipients.
    Bujnowska A; Michon M; Konopelski P; Hryniewiecka E; Jalbrzykowska A; Perkowska-Ptasinska A; Cieciura T; Zagozdzon R; Paczek L; Ciszek M
    Transplant Proc; 2018; 50(6):1720-1725. PubMed ID: 29961551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
    Han S; Hwang E; Park S; Park U; Kim H; Cho W
    Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Eculizumab for Active Antibody-mediated Rejection That Occurs Early Post-kidney Transplantation: A Consecutive Series of 15 Cases.
    Tan EK; Bentall A; Dean PG; Shaheen MF; Stegall MD; Schinstock CA
    Transplantation; 2019 Nov; 103(11):2397-2404. PubMed ID: 30801549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eculizumab to treat antibody-mediated rejection in a 7-year-old kidney transplant recipient.
    Chehade H; Rotman S; Matter M; Girardin E; Aubert V; Pascual M
    Pediatrics; 2015 Feb; 135(2):e551-5. PubMed ID: 25624380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study.
    Lonze BE; Bae S; Kraus ES; Holechek MJ; King KE; Alachkar N; Naqvi FF; Dagher NN; Sharif A; Desai NM; Segev DL; Montgomery RA
    Transpl Int; 2017 Sep; 30(9):874-883. PubMed ID: 28403566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of ABO-Incompatible Living Donor Renal Transplantations: A Single-Center Experience From Eastern India.
    Ray DS; Thukral S
    Transplant Proc; 2016 Oct; 48(8):2622-2628. PubMed ID: 27788792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid accomodation of an A1 renal allograft after preconditioning for ABO-incompatible transplantation.
    Allen G; Simpkins CE; Segev D; Warren D; King K; Taube J; Locke J; Baldwin W; Haas M; Chivukula R; Montgomery RA
    Contrib Nephrol; 2009; 162():35-46. PubMed ID: 19001812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical role of plasmapheresis in ABO-incompatible renal transplantation.
    Tobian AA; Shirey RS; Montgomery RA; Ness PM; King KE
    Transfusion; 2008 Nov; 48(11):2453-60. PubMed ID: 18657072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eculizumab for Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: A Single-Center Experience.
    Yelken B; Arpalı E; Görcin S; Kocak B; Karatas C; Demiralp E; Turkmen A
    Transplant Proc; 2015; 47(6):1754-9. PubMed ID: 26293046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Blood Group Antibodies in Intravenous Immunoglobulin May Complicate Interpretation of Antibody Titers in ABO-Incompatible Transplantation.
    Staley EM; Carruba SS; Manning M; Pham HP; Williams LA; Marques MB; Locke JE; Lorenz RG
    Am J Transplant; 2016 Aug; 16(8):2483-6. PubMed ID: 26913485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current progress in ABO-incompatible liver transplantation.
    Tanabe M; Kawachi S; Obara H; Shinoda M; Hibi T; Kitagawa Y; Wakabayashi G; Shimazu M; Kitajima M
    Eur J Clin Invest; 2010 Oct; 40(10):943-9. PubMed ID: 20636381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO-incompatible kidney transplantation.
    Takahashi K; Saito K
    Transplant Rev (Orlando); 2013 Jan; 27(1):1-8. PubMed ID: 22902167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO incompatible renal transplantation: a paradigm ready for broad implementation.
    Montgomery RA; Locke JE; King KE; Segev DL; Warren DS; Kraus ES; Cooper M; Simpkins CE; Singer AL; Stewart ZA; Melancon JK; Ratner L; Zachary AA; Haas M
    Transplantation; 2009 Apr; 87(8):1246-55. PubMed ID: 19384174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.